Saturday, 30 March 2024
Karyopharm Therapeutics Inc.
NASDAQ : KPTI
4.790 14 Oct 22 00:00 | Change: 0.33 | Open: 5.180 | High: 5.225 | Ask: 0.000 | Volume: 1,285,300 |
Change(%): 6.45 | Prev: 5.120 | Low: 4.770 | Bid: 0.000 | Avg vol: 0 |
05:07 | 16/3/18
Market Exclusive
On March15, 2018, Karyopharm Therapeutics Inc. (the “Company”) announced its financial results for the quarter and fiscal year ended December31, 2017 and will conduct a previously-announced, publicly available conference call to discuss those results ...
more»
00:26 | 16/3/18
Yahoo News UK
NEWTON, Mass. (AP) _ Karyopharm Therapeutics Inc. (KPTI) on Thursday reported a loss of $39 million in its fourth quarter. The Newton, Massachusetts-based company said it had a loss of 80 cents per share.
more»
23:52 | 15/3/18
GlobeNewswire
NEWTON, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today reported financial results for the fourth quarter and full year 2017 and provided an overview of recent ...
more»
03:16 | 15/3/18
Nasdaq Fortune
Karyopharm Therapeutics Inc. (KPTI) shares were closed at $17.01 a share in the latest session and the stock value loss almost -1.39% since the beginning of this year.
more»
01:43 | 15/3/18
NMSU H?r?ld
Art Advisors Ltd Liability Company reported 0.01% of its portfolio in Karyopharm Therapeutics Inc. (NASDAQ:KPTI). Moreover, Raymond James And Assocs has 0% invested in Karyopharm Therapeutics Inc. (NASDAQ:KPTI). 9,318 were reported by Legal And General ...
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |